glp-1 vs sglt2 weight loss Emerging Role of SGLT-2 Inhibitors for the Treatment of Obesity | Drugs Recommendations for SGLT2i versus GLP-1

Product Information

One of my favorite pieces of tech history is that the men who built the first steam engines didnt actually understand how their machines worked

Whether you're considering Wegovy, Zepbound, Ozempic, Mounjaro, bariatric surgery, or the Medicare GLP-1 Bridge Program, our insurance specialists are here to help you understand your coverage before treatment begins

Because retatrutide has not completed the FDA approval process, it cannot legally be prescribed, marketed as a treatment, or sold as a finished medical product for individual use in the United States

While all GLP-1 medications may promote some weight loss, three drugs are specifically indicated for chronic weight management: Zepbound (tirzepatide) Wegovy (semaglutide) Saxenda (liraglutide) Multiple clinical trials have found that each of these medications can help people lose 5%-20% or more of their body weight though research suggests that some may be more effective than others